Skip to main content
Clinical Trials/CTRI/2024/02/063009
CTRI/2024/02/063009
Recruiting
Phase 3

Comparison of efficacy and safety of Prednisolone 20 mg vs Placebo in Diabetic patients with Complex Regional Pain Syndrome of upper extremity - PPDCRPS

Professor Jayantee Kalita0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: G894- Chronic pain syndrome
Sponsor
Professor Jayantee Kalita
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Professor Jayantee Kalita

Eligibility Criteria

Inclusion Criteria

  • A) Continuous pain which is disproportionate to any inciting factor.
  • B) At least one symptom in three of the four following domains.
  • 1\) Sensory: hyperesthesia with or without allodynia.
  • 2\) Vasomotor: Asymmetry in temperature or skin color, skin color changes of the affected limb.
  • 3\) Sudomotor/edema: Presence of edema, sweating changes or sweating asymmetry.
  • 4\) Motor/ trophic: Reduced range of motion or motor dysfunction with or without trophic changes of the limb.
  • C). At least one sign in \= 2 of the following domains.
  • 1\) Sensory: Hyperalgesia (to pin prick) with or without allodynia (light touch, deep somatic presence or joint movements).
  • 2\) Vasomotor: Evidence of temperature or skin color asymmetry, or skin color changes.
  • 3\) Sudomotor/edema: edema, sweating changes or sweating asymmetry.

Exclusion Criteria

  • Patients with uncontrolled hypertension, diabetes, infection, organ
  • failure, malignancy, shoulder joint dislocation or infection, pregnancy and unwilling for consent will be excluded

Outcomes

Primary Outcomes

Not specified

Similar Trials